Internship

Co-op Recombinant Mammalian MSAT USP

Posted on 10/25/2024

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

No H1B Sponsorship

Framingham, MA, USA

Must be able to relocate to Framingham, MA and work 40 hours/week, Monday-Friday.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Required Skills
Python
PowerPoint/Keynote/Slides
Requirements
  • Currently pursuing a Bachelor's or Master's degree in Computational Science, Bioengineering, Chemical Engineering, Biotechnology, Biochemistry or related field at an accredited college or university with the expectation that you will complete your current degree by the Spring of 2027
  • Must be enrolled in school the semester following your co-op with Sanofi
  • Must be able to relocate to the office location and work 40hrs/week, Monday-Friday, for the full duration of the co-op
  • Must have permanent US work authorization
  • Hands-on experience in mammalian cell culture/aseptic technique, and cell biology techniques
  • Experience with Python coding
  • Basic understanding of general concepts of cell biology, biochemistry, and laboratory procedures
  • Ability to work in Biosafety Level 2 environment and follow lab safety procedures
  • Proficiency in Microsoft Office software (excel, PowerPoint, word)
  • Excellent communication skills, written and verbal; able to effectively communicate with supervisor and team members
  • Highly organized with a keen attention to details
Responsibilities
  • Work on an MSAT development project, to include execution of cell culture bioreactor operations and analytical equipment such as amino acid analyzer and Raman spectroscopy, etc.
  • In particular, in-silico simulations and the coding of metabolic flux analysis are used to quantify cell metabolism
  • Update the team during regular meeting and give a presentation at the end of the projects

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical needs. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse pipeline of products. The company's goal is to enhance health outcomes and improve the quality of life for people globally.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's AI tool Muse accelerates patient recruitment in clinical trials.
  • Dupixent's EU approval expands Sanofi's pediatric treatment market.
  • BrightInsight partnership enhances digital health solutions for better patient outcomes.

What critics are saying

  • Increased competition in the rare disease sector from biotech startups.
  • Regulatory risks due to liver enzyme elevations in tolebrutinib trials.
  • Dependence on strategic partnerships like BrightInsight for digital health initiatives.

What makes Sanofi unique

  • Sanofi's Care4Rare program supports innovative solutions for rare diseases.
  • The MyWay app enhances patient engagement and medication adherence.
  • Tolebrutinib is the first brain-penetrant BTK inhibitor for multiple sclerosis.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE